Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-071611

EVP, Research & CSO sold 1,375 shares at $39.95 ($54,931)

  • EVP, Research & CSO acquired 1,375 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Virgin Herbert · EVP, Research & CSO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-12-28 Exercise or conversion : show line 1 in the form +1,375 $1.53 $2,104 109,075 D
2021-12-28 Sale : show line 2 in the form −1,375 $39.95 $54,931 107,700 D
Open-market sales · 1,375 sh · avg $39.95 · $54,931

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-12-28 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −1,375 225,005 D
Loading xslF345X03/doc4.xml…